QA: Biovie INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001580149_2024_Biovie_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001580149, Biovie INC

  xvar xval
0 AssetsCurrent 34,041,135
1 IntangibleAssetsNetIncludingGoodwill 982,806
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 80,789
4 LiabilitiesCurrent 14,494,669
5 LiabilitiesNoncurrent 42,505
6 remainder_Liabilities 5,227,270
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,974,588
9 ResearchAndDevelopmentExpense 111,936,802
10 remainder_Expenses 179,289
11 remainder_Revenues 0
12 remainder_NetIncome -5,175,367
13 remainder_ComprehensiveNetIncome 176,591
  yvar yval
0 Assets 35,104,730
1 Liabilities 19,764,444
2 Expenses 124,090,679
3 Revenues 0
4 StockholdersEquity 15,340,286
5 NetIncome -129,266,046
6 ComprehensiveNetIncome -129,177,750
7 BaseVar 92,155,906
8 EconomicCapitalRatiobeforeLimitedLiability -3.49
9 EconomicCapitalRatio 0.532

Edgar->Model Mapping

Feature Distribution

Change over Time